Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Lake Street Initiates Coverage On Oncolytics Biotech with Buy Rating, Announces Price Target of $7

Author: Benzinga Newsdesk | August 13, 2025 11:00am

Lake Street analyst Chad Messer initiates coverage on Oncolytics Biotech (NASDAQ:ONCY) with a Buy rating and announces Price Target of $7.

Posted In: ONCY